Share class: BRAIN Biotech AG

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 21,847,495 8,602,795 ( 39.38 %) 0 39.38 %

Major shareholders: BRAIN Biotech AG

NameEquities%Valuation
46.56 %
10,172,364 46.56 % 30 M €
5.6 %
1,223,459 5.6 % 4 M €
Universal-Investment-Gesellschaft mbH (Invt Mgmt)
2.988 %
652,894 2.988 % 2 M €
FPM Frankfurt Performance Management AG
1.813 %
396,000 1.813 % 1 M €
Joh. Berenberg, Gossler & Co. KG (Investment Management)
0.9241 %
201,894 0.9241 % 597 528 €
Generali Investments LLC
0.1665 %
36,373 0.1665 % 107 650 €
SMS & Cie. Vermögensmanagement GmbH
0.0915 %
20,000 0.0915 % 59 192 €
Deutsche Bank AG (Private Banking Germany)
0.0867 %
18,940 0.0867 % 56 055 €
KIRIX Vermögensverwaltung AG
0.0549 %
12,000 0.0549 % 35 515 €
ARS Vivendi Advisors UG
0.0267 %
5,844 0.0267 % 17 296 €

Breakdown by shareholder type

Individuals52.16%
Institutional6.15%
Unknown41.69%

Based on 1000 largest holdings

Geographical origin of shareholders

Individuals
52.16%
Germany
5.98%
Slovenia
0.17%

Based on 1000 largest holdings

Logo BRAIN Biotech AG
BRAIN Biotech AG, is formerly known as B.R.A.I.N. Biotechnology Research and Information Network AG, is a Germany -based Company. The Company is a supplier of bio-based products and solutions such as enzymes and proteins, microbial production strains, natural substances, and biotechnological solutions for industrial processes in the areas of nutrition, health, and the environment. BRAIN Biotech is also offers contract research and development in the fields of enzyme technology, microbial strain development and bioprocess development.
Employees
292
More about the company